Cargando…
Sorafenib Attenuates Fibrotic Hepatic Injury Through Mediating Lysine Crotonylation
BACKGROUND: Liver fibrosis is an independent contributor of chronic liver diseases, and regressing liver fibrosis is considered a potential therapeutic target for chronic liver diseases. We aimed to explore the effects and mechanism of sorafenib in liver fibrosis. METHODS: Male Sprague Dawley (SD) r...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9262635/ https://www.ncbi.nlm.nih.gov/pubmed/35812135 http://dx.doi.org/10.2147/DDDT.S368306 |